Repositorio Digital

Consenso Argentino en gestión efectiva de clínicas de anticoagulación para el uso de antagonistas de la vitamina K

Mostrar el registro sencillo del ítem Ceresetto, José Duboscq, Cristina Korin, Jorge Fondevila, Carlos Casais, Patricia Rossi, Andrea Scazziota, Alejandra Martinuzzo, Marta Aris Cancela, María Esther Rosa, Claudio Pombo, Gonzalo Guimelli, Carla Adamczuk, Yolanda Martí, Alejandra Penchasky, Diana Riveros, Dardo Puente, Dolores Celebrin, Lucía Molnar, Soledad Meschengieser, Susana Castro Ríos, Miguel Blanco, Alicia Hendler, Héctor Brodsky, Andrés Sánchez Luceros, Analía Negri Aranguren, Pedro Fedele, José Luis Merlo, Claudio Raña, Pablo Gumpel, Carina Colorio, Cecilia Grand, Beatriz Canónico, Virginia Rossi, Eleonora Colimodio, Paulo et. al. 2021-03-01T15:28:53Z 2021-03-01T15:28:53Z 2020-09
dc.description Fil: Martí A. Hospital El Cruce - Néstor Kirchner, Florencio Varela, Provincia de Buenos Aires; Argentina. es_AR
dc.description.abstract Treating an anticoagulated patient with vitamin K antagonists (VKA) remains a challenge, especially in areas where dicoumarins are still the first drug of choice due to the cost of other oral anticoagulants. Anticoagulation clinics have proven to be the most efficient and safe way to avoid thrombotic and hemorrhagic complications and to keep patients in optimal treatment range. However, they require adequate infrastructure and trained personnel to work properly. In this Argentine consensus we propose a series of guidelines for the effective management of the anticoagulation clinics. The goal is to achieve the excellence in both the clinical healthcare and the hemostasis laboratory for the anticoagulated patient. The criteria developed in the document were agreed upon by a large group of expert specialists in hematology and biochemistry from all over the country. The criteria presented here must always be considered when indicating VKA although they had to be adapted to the unequal reality of each center. Taking these premises into consideration will allow us to optimize the management of the anticoagulated patient with VKA and thus minimize thrombotic and hemorrhagic intercurrences, in order to honor our promise not to harm the patient. es_AR
dc.language.iso es es_AR
dc.relation.ispartofseries MEDICINA (Buenos Aires);2020;80 Suppl 4:1-26
dc.subject Anticoagulantes es_AR
dc.subject Vitamina K es_AR
dc.title Consenso Argentino en gestión efectiva de clínicas de anticoagulación para el uso de antagonistas de la vitamina K es_AR
dc.type Article es_AR

Ficheros en el ítem

Este ítem aparece en la(s) siguiente(s) colección(ones)

Mostrar el registro sencillo del ítem